Works matching AU Oya, Mototsugu

Results: 387
    1
    2
    3

    Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration‐Resistant Prostate Cancer: PROpel Subset Analysis.

    Published in:
    Cancer Science, 2025, v. 116, n. 6, p. 1638, doi. 10.1111/cas.16459
    By:
    • Oya, Mototsugu;
    • Joung, Jae Young;
    • Lee, Ji Youl;
    • Sugimoto, Mikio;
    • Choi, Young Deuk;
    • Hong, Jun Hyuk;
    • Uemura, Hiroji;
    • Nishimura, Kazuo;
    • Tsumura, Hideyasu;
    • Kawakami, Satoru;
    • Hirayama, Yukiyoshi;
    • Kwon, Tae Gyun;
    • Kwak, Cheol;
    • Suzuki, Hiroyoshi;
    • Fujita, Tomoko;
    • Nii, Masahiro;
    • McGuinness, David;
    • Dujka, Melanie;
    • Poehlein, Christian;
    • Saad, Fred
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Brain metastasis of a papillary renal cell carcinoma, identified as type 2.

    Published in:
    International Journal of Clinical Oncology, 2009, v. 14, n. 3, p. 270, doi. 10.1007/s10147-008-0840-9
    By:
    • Hasegawa, Masanori;
    • Kikuchi, Eiji;
    • Yasumizu, Yota;
    • Hattori, Seiya;
    • Takeda, Toshikazu;
    • Morita, Shinya;
    • Kosaka, Takeo;
    • Miyajima, Akira;
    • Horiguchi, Takashi;
    • Mikami, Shuji;
    • Oya, Mototsugu
    Publication type:
    Article
    11
    12
    13
    14
    15

    Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 16, doi. 10.1093/jjco/hyac155
    By:
    • Tomita, Yoshihiko;
    • Kobayashi, Ko;
    • Kimura, Go;
    • Oya, Mototsugu;
    • Uemura, Hirotsugu;
    • Nishiyama, Hiroyuki;
    • Galsky, Matthew D;
    • Nasroulah, Federico;
    • Collette, Sandra;
    • Broughton, Edward;
    • Ünsal-Kaçmaz, Keziban;
    • Kamisuki, Yukinori;
    • Bajorin, Dean F
    Publication type:
    Article
    16
    17

    Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1770, doi. 10.1093/jjco/hyab161
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    18

    Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 11, p. 1656, doi. 10.1093/jjco/hyab114
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    19
    20
    21
    22
    23

    Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1313, doi. 10.1093/jjco/hyaa114
    By:
    • Ito, Keiichi;
    • Mikami, Shuji;
    • Kuroda, Naoto;
    • Nagashima, Yoji;
    • Tatsugami, Katsunori;
    • Masumori, Naoya;
    • Kondo, Tsunenori;
    • Takagi, Toshio;
    • Nakanishi, Shotaro;
    • Eto, Masatoshi;
    • Kamba, Tomomi;
    • Tomita, Yoshihiko;
    • Matsuyama, Hideyasu;
    • Tsushima, Tomoyasu;
    • Nakazawa, Hayakazu;
    • Oya, Mototsugu;
    • Kimura, Go;
    • Shinohara, Nobuo;
    • Asano, Tomohiko
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 69, doi. 10.1093/jjco/hyy154
    By:
    • Ito, Keiichi;
    • Masunaga, Ayako;
    • Tanaka, Nobuyuki;
    • Mizuno, Ryuichi;
    • Shirotake, Suguru;
    • Yasumizu, Yota;
    • Ito, Yujiro;
    • Miyazaki, Yasumasa;
    • Hagiwara, Masayuki;
    • Kanao, Kent;
    • Mikami, Shuji;
    • Momma, Tetsuo;
    • Masuda, Takeshi;
    • Nakagawa, Ken;
    • Oyama, Masafumi;
    • Asano, Tomohiko;
    • Oya, Mototsugu
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Invasion and metastasis of renal cell carcinoma.

    Published in:
    Medical Molecular Morphology, 2014, v. 47, n. 2, p. 63, doi. 10.1007/s00795-013-0064-6
    By:
    • Mikami, Shuji;
    • Oya, Mototsugu;
    • Mizuno, Ryuichi;
    • Kosaka, Takeo;
    • Katsube, Ken-ichi;
    • Okada, Yasunori
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 7, p. 1197, doi. 10.1007/s00432-014-1638-y
    By:
    • Inamoto, Teruo;
    • Azuma, Haruhito;
    • Hinotsu, Shiro;
    • Tsukamoto, Taiji;
    • Oya, Mototsugu;
    • Ogawa, Osamu;
    • Kitamura, Tadaichi;
    • Kazuhiro, Suzuki;
    • Naito, Seiji;
    • Namiki, Mikio;
    • Nishimura, Kazuo;
    • Hirao, Yoshihiko;
    • Usami, Michiyuki;
    • Murai, Masaru;
    • Akaza, Hideyuki
    Publication type:
    Article
    45
    46
    47
    48

    Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1903, doi. 10.1007/s00262-023-03367-w
    By:
    • Shiota, Masaki;
    • Miyake, Hideaki;
    • Takahashi, Masayuki;
    • Oya, Mototsugu;
    • Tsuchiya, Norihiko;
    • Masumori, Naoya;
    • Matsuyama, Hideyasu;
    • Obara, Wataru;
    • Shinohara, Nobuo;
    • Fujimoto, Kiyohide;
    • Nozawa, Masahiro;
    • Ohba, Kojiro;
    • Ohyama, Chikara;
    • Hashine, Katsuyoshi;
    • Akamatsu, Shusuke;
    • Kamba, Tomomi;
    • Mita, Koji;
    • Gotoh, Momokazu;
    • Tatarano, Shuichi;
    • Fujisawa, Masato
    Publication type:
    Article
    49

    Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 3001, doi. 10.1007/s00262-021-03006-2
    By:
    • Murakami, Tetsushi;
    • Tanaka, Nobuyuki;
    • Takamatsu, Kimiharu;
    • Hakozaki, Kyohei;
    • Fukumoto, Keishiro;
    • Masuda, Tsukasa;
    • Mikami, Shuji;
    • Shinojima, Toshiaki;
    • Kakimi, Kazuhiro;
    • Tsunoda, Tatsuhiko;
    • Sawada, Kazuaki;
    • Imamura, Takeshi;
    • Mizuno, Ryuichi;
    • Oya, Mototsugu
    Publication type:
    Article
    50